Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography

NCT01689688 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2013-09-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate serial changes of neointimal coverage after everolimus-eluting stent implantation at 3-, 6- and 12-months by OCT examination.

Conditions

Sponsors & Collaborators

  • Kobe University

    lead INDUSTRY

Principal Investigators

  • Toshiro Shinke · Kobe University Graduate School of Medicine

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-09-30
Completion
2015-10-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01689688 on ClinicalTrials.gov